A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate safety and tolerability of arbaclofen placarbil
sustained release tablets taken every 12 hours compared to placebo in subjects with acute
back spasms in the lumbar region.